Exchange & Returns Information
Review Details
(0)
| Generic For | JANUMET |
|---|---|
| Active Ingredient | SITAGLIPTIN|METFORMIN |
| Strength | 50MG|1000MG |
| Manufacturer | ZYDUS CADILA |
| Pack Size | Price Per Unit | Unit Price | QTY | CART | Best Coupon Price MAX DISCOUNT |
|---|---|---|---|---|---|
| 1 BOX - 100 TABLETS | $ 0.57 | $ 57.20 |
$ 48.62
Apply ZARVY26 (-15%)
You save $ 8.58
|
||
| 2 BOXES - 200 TABLETS | $ 0.51 |
10% $ 114.40
$ 102.80
|
$ 87.38
Apply ZARVY26 (-15%)
You save $ 15.42
|
||
| ★ Best Value 3 BOXES - 300 TABLETS | $ 0.46 |
19% $ 171.60
$ 138.20
|
$ 117.47
Apply ZARVY26 (-15%)
You save $ 20.73
|
Reference information will be available soon.
Sitaglyn M 50/1000 is a combination therapy for Type 2 Diabetes management, containing Sitagliptin (DPP-4 Inhibitor) 50mg and Metformin (First-Line Therapy) 1000mg. This dual-action formula helps regulate blood sugar levels by enhancing insulin secretion, reducing hepatic glucose production, and improving insulin sensitivity. As an alternative to Janumet, Sitaglyn M 50/1000 is designed to provide long-term Glycemic Control, reduce the risk of Cardiovascular Diseases, and stabilize post-meal glucose fluctuations. The combination of DPP-4 inhibition and Metformin action supports effective diabetes management, ensuring optimal metabolic balance.
- Blood Sugar Regulation: A dual-mechanism approach that enhances insulin secretion and reduces hepatic glucose production. - First-Line Diabetes Treatment: Metformin improves insulin sensitivity, decreases glucose absorption, and stabilizes blood sugar levels. - DPP-4 Inhibitor Action: Sitagliptin prevents incretin hormone breakdown, stimulating post-meal insulin release and suppressing glucose spikes. - Glycemic Control: Helps maintain steady blood sugar levels, preventing hyperglycemia and hypoglycemia. - Cardiovascular Protection: Reduces the risk of Cardiovascular Diseases by lowering vascular stress and stabilizing metabolic function.
Sitaglyn M 50/1000 works through two primary mechanisms: - Sitagliptin (DPP-4 Inhibitor): Enhances incretin function, increasing insulin secretion and reducing excess glucose release after meals. - Metformin (First-Line Therapy): Reduces hepatic glucose production, enhances insulin efficiency, and improves Glycemic Control. This combination ensures stable blood sugar regulation, lowers cardiovascular risks, and supports long-term diabetes management.
For Diabetes > First Line Therapies: Metformin - Sitaglyn M 50/1000 is prescribed for type 2 diabetes management in patients requiring dual therapy. - Standard dosage: One tablet once or twice daily, preferably with meals to reduce gastrointestinal discomfort. - Metformin lowers liver glucose production and improves insulin sensitivity. - Extended-release formulation ensures gradual drug release, minimizing side effects like nausea. - Regular blood sugar monitoring is necessary for maintaining optimal glycemic control. For Diabetes > DPP-4 Inhibitors - Sitagliptin enhances insulin secretion and reduces liver glucose production by blocking DPP-4 enzyme activity. - Improves post-meal blood sugar control and prevents glucose spikes. - Can be combined with Metformin for enhanced glycemic management. - Helps regulate blood sugar levels without increasing the risk of hypoglycemia. For Diet > Glycemic Control - Stabilizes blood sugar levels, reducing post-meal glucose surges. - Works best when paired with a healthy diet and regular exercise. - Improves insulin response, supporting long-term diabetes control. For Lifestyle-Related Diseases > Cardiovascular Diseases - Sitagliptin and Metformin combination therapy may provide cardiovascular benefits. - May help reduce heart disease risk by improving vascular function. - Supports weight management, which is essential for heart health. Administration - Take once or twice daily with meals to reduce stomach discomfort. - Swallow whole—do not crush or chew, as it is an extended-release formulation. - Maintain adequate hydration to prevent dehydration. Do not double the dose if one is missed. - Consult a doctor for dosage adjustments based on kidney function and blood sugar levels.
- Store in a cool, dry place, away from heat and moisture. - Keep in original packaging to maintain potency and effectiveness. - Ensure it is out of reach of children and pets.
While Sitaglyn M 50/1000 is well tolerated, some users may experience: - Mild gastrointestinal discomfort (nausea, bloating, diarrhea) due to Metformin. - Headache or dizziness due to Sitagliptin. - Hypoglycemia when combined with other antidiabetic medications. - Fatigue or weakness in rare cases. Serious side effects, such as lactic acidosis, require immediate medical attention.
No reviews yet. Be the first to review this product!
No combo deals available at the moment.
